Canadian Consensus Criteria (2003)

The Canadian Consensus Criteria (Carruthers et al. 2003) emerged from a panel of physicians, researchers, and teaching faculty to provide a clinically oriented case definition emphasizing characteristic features.

1 Required Criteria

ImportantRequirement: Canadian Consensus Criteria Structure

Diagnosis requires ALL of the following:

1. Fatigue

  • Clinically evaluated, unexplained persistent or relapsing chronic fatigue
  • New or definite onset (not lifelong)
  • Not result of ongoing exertion
  • Not substantially alleviated by rest
  • Substantial reduction in previous levels of occupational, educational, social, or personal activities

2. Post-Exertional Malaise and/or Fatigue (MANDATORY)

  • Inappropriate loss of physical and mental stamina
  • Rapid muscular and cognitive fatigability
  • Post-exertional malaise and/or fatigue
  • Tendency for other associated symptoms within the patient’s cluster to worsen
  • Recovery period: Pathologically slow (24 hours or longer)

3. Sleep Dysfunction

  • Unrefreshing sleep or sleep quantity or rhythm disturbances (hypersomnia, insomnia, reversed sleep-wake cycle)

4. Pain (significant degree in at least one location)

  • Myalgia: muscle pain, aching, or stiffness
  • Arthralgia: joint pain (migratory, without joint swelling or redness)
  • Headaches of new type, pattern, or severity

5. Neurological/Cognitive Manifestations (\(\geq\) 2 required)

  • Confusion, impaired concentration/short-term memory, disorientation
  • Difficulty with information processing, categorizing, word retrieval
  • Perceptual/sensory disturbances (spatial instability, disorientation, inability to focus vision)
  • Ataxia, muscle weakness, fasciculations

6. At Least ONE Symptom from TWO of the Following Categories:

  • Autonomic Manifestations: Orthostatic intolerance (neurally mediated hypotension, POTS, delayed postural hypotension), lightheadedness, extreme pallor, nausea and irritable bowel syndrome, urinary frequency/bladder dysfunction, palpitations with or without cardiac arrhythmias, exertional dyspnea

  • Neuroendocrine Manifestations: Loss of thermostatic stability (subnormal body temperature, marked daily fluctuation), intolerance of extremes of heat and cold, marked weight change, loss of adaptability/worsening symptoms with stress

  • Immune Manifestations: Tender lymph nodes, recurrent sore throat, recurrent flu-like symptoms, general malaise, new sensitivities to food/medications/chemicals

7. Duration Illness persists \(\geq\) 6 months. May be preceded by various infections or other triggering events.

2 Exclusions

Exclude active disease processes that explain most major symptoms. Comorbid conditions do not exclude diagnosis if they do not explain the constellation of symptoms.

3 Strengths and Limitations

Strengths

  • Emphasis on post-exertional malaise as mandatory criterion
  • Comprehensive symptom coverage across multiple systems
  • Widely adopted in clinical practice
  • More specific than Fukuda criteria

Limitations

  • Complex algorithm may be difficult to apply consistently
  • Selects more severely affected patients (lower sensitivity for mild cases)
  • Some symptom requirements (e.g., “significant degree”) lack operational definitions
  • Not validated against objective biomarkers or treatment response

References

Carruthers, Bruce M, Anil Kumar Jain, Kenny L De Meirleir, Daniel L Peterson, Nancy G Klimas, A Martin Lerner, Alison C Bested, et al. 2003. “Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols.” Journal of Chronic Fatigue Syndrome 11 (1): 7–115. https://doi.org/10.1300/J092v11n01_02.